HEAL vs THNR: Holdings Overlap & Returns
Over the year to Nov 13, 2026, HEAL returned +0.2% to THNR's +6.7%; 0% of their weight is in the same names.
- Return gap
- +6.5 pts1 year to Nov 13, 2026: THNR ahead, total return
- Fee gap
- 0.09 ptsA year: HEAL 0.50%, THNR 0.59%, per filings dated Jan 28, 2026 and Mar 27, 2026
- Overlap
- 0%Share of the two books held in common, holdings dated Nov 11, 2026 and Nov 13, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
HEAL +0.2%, THNR +6.7%: THNR +6.5 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in HEAL costs about $33.00 one way and $66.00 in and out, at a median spread of 0.66%. The 0.66% spread is HEAL’s 30-day median, from Global X (fund page).
Fees over time
Hypothetical. $10,000 in THNR for 10 years at 0.59% a year costs about $972 in fees and lost growth; HEAL at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
27% of HEAL's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 11, 2026.
46% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.
Key numbers
HEAL costs 0.09 points a year less; their one-year returns differ by 6.5 points; HEAL is 7.2 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +0.2% | +6.7% |
|---|---|---|
| Below its all-time high | 55.5%, high on Feb 12, 2021 | 6.3%, high on Aug 25, 2026 |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.50% | 0.59% |
| Net assets, as of Nov 11, 2026 | $38m | $5.3m |
| Active share vs the S&P 500 | 100% | 96% |
| Holdings in common | 0% |
The numbers behind it
Net assets: $38m on Nov 11, 2026 for Global X HealthTech ETF, and $5.2m on Nov 12, 2026 for Amplify Weight Loss Drug & Treatment ETF.
Holdings in common uses holdings dated Nov 11, 2026 and Nov 13, 2026.
What they share
By the books each fund has filed, HEAL and THNR hold 0% of their money in the same securities at the same weight. Holdings dated Nov 11, 2026 and Nov 13, 2026.
half
0% in common
Only in HEAL
Show all 8 holdings
| VEEVA SYSTEMS INC-CLASS A | 6.13% |
| IQVIA HOLDINGS INC | 6.00% |
| OSCAR HEALTH INC - CLASS A | 5.62% |
| PRO MEDICUS LTD | 4.98% |
| TEMPUS AI INC-CL A | 4.98% |
| GE HEALTHCARE TECHNOLOGY | 4.66% |
| DEXCOM INC | 4.51% |
| RESMED INC | 4.00% |
Only in THNR
Show all 8 holdings
| Eli Lilly & Co | 12.10% |
| Novo Nordisk A/S | 8.89% |
| Amgen Inc | 6.11% |
| Regeneron Pharmaceuticals Inc | 6.05% |
| AstraZeneca PLC | 5.79% |
| Roche Holding AG | 5.68% |
| Gilead Sciences Inc | 5.66% |
| AbbVie Inc | 5.65% |
Side by side
Open the table
| Fund | Global X HealthTech ETF · Holds 39 stocks in healthcare innovation and GLP-1, 27% of its weight in S&P 500 companies | Amplify Weight Loss Drug & Treatment ETF · Holds 21 stocks in healthcare innovation and GLP-1, 46% of its weight in S&P 500 companies |
| Issuer | Global X | Amplify |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 27.0% | 45.8% |
| Active share vs the S&P 500 | 99.6% | 96.5% |
| In the Nasdaq-100 | 7.9% | 17.8% |
| Holdings | 39 | 21 |
| Top ten, share of the fund | 48.6% | 66.3% |
| Expense ratio | 0.50% | 0.59% |
| Fee for the differing part | 0.50% | 0.61% |
| Total return, 1 year | +0.2% | +6.7% |
| vs its benchmark | not measured | not measured |
| Below its high | −55.5% | −6.3% |
| Net assets, HEAL as of Nov 11, 2026 and THNR as of Nov 12, 2026 | $38m | $5.2m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +2.9% | −0.1% |
|---|---|---|
| 6 months | +24.6% | +7.0% |
| 1 year | +0.2% | +6.7% |
| 3 years | +15.7% | – |
| Since launch (Not the same days: HEAL Jul 2020 · THNR May 2024) | −35.3% | +5.6% |
– means no data for this window.
From May 2024 to Nov 2026, HEAL returned more: +11.1% to +5.9%. THNR swung less: 20.1% to 23.6%. THNR fell slightly less at its worst: −30.0% to −32.2%.
Full scorecard
Open the table
| Total return | +11.1% | +5.9% | HEAL | Price change plus distributions, reinvested. |
| Annualized | +4.4% | +2.3% | HEAL | Total return as a yearly rate. |
| Price return | +10.8% | +3.2% | HEAL | Price change alone, distributions left out. |
| Volatility | 23.6% | 20.1% | THNR | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 15.9% | 14.2% | THNR | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −32.2% | −30.0% | THNR (slight) | Deepest fall from a high to the low after it. |
| Sharpe | 0.12 | 0.01 | HEAL | Return above Treasury bills per unit of volatility. |
| Sortino | 0.18 | 0.01 | HEAL | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.14 | 0.08 | HEAL | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 128 weekly returns. Cash rate: the 13-week Treasury bill.
About HEAL
By weight, 27% of HEAL's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 49% of the fund across 39 positions, as published by its issuer for Nov 11, 2026.
More
Over the year to Nov 13, 2026 the fund returned +0.2% with distributions reinvested. It sits 55.5% below its all-time high of Feb 12, 2021.
About THNR
By weight, 46% of THNR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 66% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.
More
Over the year to Nov 13, 2026 the fund returned +6.7% with distributions reinvested. It sits 6.3% below its all-time high of Aug 25, 2026.
0% of the two portfolios are the same securities at the same weight.
Questions people ask
Do HEAL and THNR hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, HEAL against THNR, data as of Nov 13, 2026. https://etfiq.com/compare/themes/heal-vs-thnr
ETFIQ. (Nov 13, 2026). HEAL against THNR. Retrieved from https://etfiq.com/compare/themes/heal-vs-thnr
[HEAL against THNR (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/heal-vs-thnr)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.